Indraprastha Medical Corporation Q1 FY27 Results

Revenue from operations ₹406.15 crore; Profit After Tax ₹55.85 crore.

Reader Takeaway: Steady year-on-year growth in revenue and profit; AGM and dividend dates announced.

What just happened

Indraprastha Medical Corporation Ltd announced its financial results for the quarter ended June 30, 2026. The company reported revenue from operations of ₹406.15 crore, an increase of 11.2% compared to ₹365.06 crore in the same period last year.

Profit After Tax (PAT) for the quarter rose by 8.5% to ₹55.85 crore, up from ₹51.46 crore in the corresponding quarter of the previous fiscal year. The company also posted basic and diluted Earnings Per Share (EPS) of ₹6.09.

Why this matters

The results indicate steady financial performance and growth for Indraprastha Medical. Investors can see a clear upward trend in both the company's top line (revenue) and bottom line (profit). The announcement also provides key dates for corporate actions.

The backstory

Indraprastha Medical Corporation operates in the healthcare sector. The company has a single reporting segment (Healthcare) and no subsidiaries or joint ventures, which simplifies its financial structure and makes it easier for investors to analyze performance.

What changes now

With these results, the company demonstrates continued operational strength. Shareholders can look forward to potential dividend payouts and participation in the Annual General Meeting. The re-appointment of cost auditors ensures continued compliance.

Risks to watch

While the results show growth, investors should monitor broader healthcare sector trends and any specific regulatory changes that could impact the company's operations and profitability.

Peer comparison

Indraprastha Medical operates in the healthcare services sector. Direct comparison with peers like Apollo Hospitals or Fortis Healthcare would require analyzing similar quarterly results and operational footprints.

Context metrics

• Revenue from Operations (Q1 FY27): ₹406.15 crore (vs. ₹365.06 crore in Q1 FY26)
• Profit After Tax (Q1 FY27): ₹55.85 crore (vs. ₹51.46 crore in Q1 FY26)
• EPS (Q1 FY27): ₹6.09

What to track next

Investors should track future quarterly results, management commentary on growth strategies, and any announcements related to the company's expansion or new service offerings. The dividend payout and AGM proceedings will also be key events.

Corporate Actions

The Board has approved convening the 38th Annual General Meeting (AGM) on September 24, 2026, via video conferencing. September 18, 2026, has been fixed as the record date for determining shareholder entitlements for the financial year 2025-26 dividend and AGM attendance. M/s Devarajan Swaminathan and Co. have been re-appointed as Cost Auditors for FY2026-27.